The National Institutes of Health Stroke Scale and its importance in acute stroke management.
The National Institutes of Health (NIH) stroke scale is a standardized neurologic examination developed to quantitate the patient's deficits in clinical trials for new stroke therapies. It is used on admission to determine patient eligibility for thrombolytic therapy, throughout the acute hospital stay, and at 3 months to assess neurologic recovery. The NIH stroke scale scores correlates with initial infarct volume, cerebral perfusion, and functional outcome.
Odderson
I R
IR
Department of Rehabilitation Medicine, University of Washington, Seattle, USA.
D006801:Humans; D009316:National Institutes of Health (U.S.); D009483:Neuropsychological Tests; D010960:Plasminogen Activators / Q000627:therapeutic use; D011379:Prognosis; D015203:Reproducibility of Results; D020521:Stroke / Q000175:diagnosis*; D015912:Thrombolytic Therapy / Q000009:adverse effects; D014481:United States
D010960:Plasminogen Activators